DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

159.97 -1.54 (-0.95%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $159.97 -0.95%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $160.24
Previous Close $161.51
Daily Range $158.35 - $161.73
52-Week Range $106.00 - $162.80
Market Cap $53.7B
P/E Ratio 104.88
Dividend (Yield) $0.00 (0.0%)
Volume 1,409,782
Average Daily Volume 2,051,663
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

Health Care Sector Update for 01/30/2015: ICPT,QTNT,DNDNQ, VRX

Dendreon's Asset Rummage Sale Completes the Circle of Life

3 Stocks Boosting The Drugs Industry Higher

New Guru Jana Partners' Newest Stock Buys

A Look At Actavis

Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog

Why Valeant Pharmaceuticals (VRX) Isn't Done Growing Earnings Yet - Tale of the Tape

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formular

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formulary Concerns Are Noise

Valeant CEO On Allegations Against The Company And Future M&A Deals

New Lifetime High Today: Valeant Pharmaceuticals International (VRX)

See More VRX News...

VRX's Top Competitors

VRX $159.97 (-0.95%)
Current stock: VRX
JNJ $100.14 (-2.19%)
Current stock: JNJ
NVS $97.40 (-1.77%)
Current stock: NVS
RHHBY $33.78 (-1.75%)
Current stock: RHHBY